Skip to main navigation Skip to search Skip to main content

Endosaccular flow disruption: Where are we now?

  • Pervinder Bhogal
  • , Sundip Udani
  • , Christophe Cognard
  • , Michel Piotin
  • , Patrick Brouwer
  • , Nader Antoine Sourour
  • , Tommy Andersson
  • , Levansri Makalanda
  • , Ken Wong
  • , David Fiorella
  • , Adam S. Arthur
  • , Leonard L.L. Yeo
  • , Michael Soderman
  • , Hans Henkes
  • , Laurent Pierot
  • Barts Health NHS Trust
  • CHU de Toulouse
  • Fondation Rothschild Hospital
  • Karolinska Institutet
  • Sorbonne Université
  • Semmes Murphey Neurologic & Spine Institute
  • MOH Holdings Pte Ltd.
  • Klinikum Stuttgart
  • University Hospital Reims

Research output: Contribution to journalArticlepeer-review

51 Scopus citations

Abstract

Endosaccular flow disruption is an innovative method of treating wide-necked complex aneurysms. Currently four types of devices have obtained the CE mark for use within Europe. These are the Woven EndoBridge device (WEB), the Luna Aneurysm Embolization System, the Medina Embolic Device (Medtronic), and the Contour Neurovascular System. The aim of this article is to provide an overview of these devices and to summarize the evidence in the literature pertaining to the treatment of intracranial aneurysms with them.

Original languageEnglish
Pages (from-to)1024-1035
Number of pages12
JournalJournal of NeuroInterventional Surgery
Volume11
Issue number10
DOIs
StatePublished - Oct 1 2019

Keywords

  • contour
  • flow disruption
  • LUNA AES
  • MED
  • WEB

Fingerprint

Dive into the research topics of 'Endosaccular flow disruption: Where are we now?'. Together they form a unique fingerprint.

Cite this